Galen completes femhrt acquisition

Pharmaceuticals business Galen Holdings has completed the acquisition of femhrt, the hormone replacement therapy.

Galen bought the rights to femhrt from Pfizer.

The deal by Galen, based in Craigavon in Northern Ireland, was first announced last month.